HALEON HOLDINGS (NO. 2) LLC

1. HALEON HOLDINGS (NO. 2) LLC 2024-02-07 → present
2. GSK CONSUMER HEALTHCARE HOLDINGS NO. 2 LLC 2020-03-31 → 2024-02-07

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Audit opinion

Unaudited (audit-exempt)

Going concern

Affirmed

“Having assessed the principal risks and considered other matters, the Directors are of the opinion that the current level of activity remains sustainable. In relation to the potential downside scenarios, the considerations have included the potential risks to asset valuations and cashflow generation. The Directors have taken into account that as part of the Group, the Company has the ability to request support from the Group where necessary and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”

Group structure

1. HALEON HOLDINGS (NO. 2) LLC · parent
   1. Haleon Singapore Pte. Ltd. 100% · Singapore
   2. P.T. Sterling Products Indonesia 30% · Indonesia

Significant events

• “During the year, the Company received repatriation of capital from its subsidiary, GlaxoSmithKline Consumer Healthcare Pte. Ltd of £10,000k (2023: £95,000k).”
• “In order to streamline legal entities structure in Singapore, GlaxoSmithKline Consumer Healthcare Pte. Ltd was amalgamated into Haleon Singapore Pte. Ltd. This consolidation led to the transfer of the subsidiary designation from GlaxoSmithKline Consumer Healthcare Pte. Ltd to Haleon Singapore Pte. Ltd, with the carrying value of the investment of £109,291k being transferred to Haleon Singapore Pte. Ltd accordingly.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  —

  Not reported

• Net assets

  +0.1%

  £120,774,000 → £120,920,000

• Employees

  —

  Not reported

• Operating profit

  -120.8%

  £24,000 → -£5,000

• Profit before tax

  -90.9%

  £2,072,000 → £188,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers